查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828237

2025年全球組織微陣列市場報告

Tissue Microarray Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，組織微陣列市場規模強勁成長，從2024年的120.5億美元成長至2025年的131.1億美元，複合年成長率為8.8%。預測期內的成長可歸因於精準醫療、藥物研發、高效分析、慢性病盛行率上升以及生物樣本庫計畫的興起。

預計未來幾年組織微陣列市場規模將快速成長，到2029年將達到208.5億美元，複合年成長率為12.3%。預測期內的成長可歸因於數位病理學的興起、應用的不斷擴展、生物製藥行業的成長、監管支持和標準化以及人工智慧和機器學習的融合。預測期內的主要趨勢包括成像技術的進步、3D組織微陣列的發展、高內涵篩檢、標準化工作以及單細胞分析的整合。

組織晶片是一項強大的技術，通常使用石蠟塊或福馬林，可在單次實驗中全面分析多種組織和細胞類型的抗原表現。它可以同時評估多個組織樣本的蛋白質表現。

組織微陣列的主要類型包括免疫組織化學、螢光原位雜合反應(FISH)、冰凍組織陣列等。免疫組織化學 (IHC) 是一種用於診斷某些癌症（例如間皮瘤）的技術，它使用視覺標記來檢測切片檢查組織中的抗原。 DNA 微陣列、聚合酵素鏈鎖反應(PCR)、新一代定序、北方印跡法和西方印漬術法等各種技術被用於腫瘤學、基因表現分析、單核苷酸多態性 (SNP) 檢測、雙鏈B-DNA 微陣列、比較雜合反應和定序生物資訊學等應用。這些技術應用於各種最終用戶，包括製藥和生物技術公司、研究機構和醫院。

2025年春季美國關稅大幅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制價格上漲，製造商面臨利潤壓力。監管挑戰進一步加劇了形勢，因為由於關稅而更換供應商通常需要醫療設備重新認證，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

組織微陣列研究報告是商業研究公司最新報告系列的一部分，該系列提供組織微陣列市場統計數據，包括全球市場規模、區域佔有率、競爭對手的組織微陣列市場佔有率、詳細的組織微陣列市場細分、市場趨勢以及組織微陣列行業的商機。本組織微陣列市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的全方位觀點。

未來五年的預測成長率為12.3%，較我們先前對該市場的預測略有下降0.1%。下降的主要原因是美國與其他國家之間的關稅影響。這種影響可能會直接影響美國，導致來自芬蘭和加拿大等主要地區的精密石蠟塊和微陣列列印組件的供應鏈中斷，這可能會增加高性能病理學研究的成本。此外，這種影響可能會透過互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，在更廣泛的範圍內顯現。

癌症發生率的上升預計將在未來推動組織微陣列市場的成長。癌症涵蓋多種可能發生在任何器官或組織的疾病，由異常細胞不受控制地增殖、突破正常邊界並可能擴散到其他器官或侵入鄰近組織引起。組織微陣列在腫瘤學中用於分析不同腫瘤樣本中癌症相關生物標記的表達。例如，根據英國癌症慈善機構麥克米倫癌症援助組織 (Macmillan Cancer Support) 2022 年 6 月發布的數據，預計英國癌症患者數量將在 2022 年達到 300 萬，到 2025 年將增至近 350 萬，到 2030 年將增至 400 萬。因此，癌症患者數量的增加正在推動組織微陣列市場的成長。

個人化醫療需求的不斷成長進一步推動了組織微陣列市場的成長。個人化醫療旨在根據個別特徵客製化治療方案，從而實現更有效的醫療保健。組織微陣列有助於同時分析多個組織樣本，從而促進生物標記的快速評估。 2022年，美國食品藥物管理局(FDA) 藥品評估與研究中心 (CDER)核准了37個新分子實體 (NME)，其中約34%被歸類為個人化醫療。這凸顯了組織微陣列在推動個人化醫療方面的關鍵作用。

組織微陣列市場的一個顯著趨勢是策略夥伴關係關係的興起。市場主要企業正在聯手開發創新的組織微陣列技術。例如，Cureline集團與Cellecta公司合作推出了Tissue 2 Target Services，整合了兩家公司在分子分析和生物樣本管理方面的能力。此外，Ultivue公司和ngTMA正在合作推進多重螢光螢光分析，並將新型組織微陣列技術應用於科學研究中的空間分析。

組織微陣列市場中的公司正專注於先進的解決方案，例如微陣列平台，以提高高效能組織分析的準確性和效率。 MARGenomics 推出了 Applied Biosystems GeneChip 3000 Dx v2，這是一款先進的微陣列平台，也是首個在美國和歐洲獲得監管部門批准用於診斷用途的平台。該平台由卡洛斯三世健康實驗室和歐盟的 NextGenerationEU舉措資助，記錄了基因組和表達微陣列的多種功能。

2022年11月，專注於臨床前和臨床研究服務的美國公司CureLine Group宣布與Cellecta Inc.合作推出Tissue 2 Target，旨在增強臨床前和轉化研究工作流程。此次合作將為專注於基因標靶和生物標記發現的研究人員打造全面的資源，簡化高品質人類生物樣本的分子表徵流程。透過利用CureLine Group在生物樣本管理方面的專業知識和Cellecta的功能基因組學技術，此次合作旨在促進循證決策，並最終改善轉化研究和臨床前計畫的成果。同樣總部位於美國的Cellecta則專注於功能基因體學，並為利用RNA干擾和CRISPR進行研究提供創新工具。

組織微陣列市場包括模具、針頭和組織穿孔器的銷售。該市場的價值指的是“出廠價”，即產品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球組織微陣列：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球組織微陣列市場：成長率分析
  • 全球組織微陣列市場表現：規模與成長，2019-2024
  • 全球組織微陣列市場預測：規模與成長，2024-2029年，2034年
  • 全球組織微陣列：總潛在市場（TAM）

第6章 市場細分

  • 全球組織微陣列市場類型、效能及預測（2019-2024、2024-2029、2034）
  • 免疫組織化學
  • 螢光原位雜合反應（FISH）
  • 冷凍組織陣列
  • 其他
  • 全球組織微陣列市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 去氧核糖核酸（DNA）微陣列
  • 聚合酵素鏈鎖反應（PCR）
  • 下一代定序
  • 北方印跡法
  • 西方印漬術
  • 全球組織微陣列市場的應用、效能與預測（2019-2024、2024-2029、2034）
  • 腫瘤學
  • 基因表現
  • 單核苷酸多態性（SNP）檢測
  • 雙鏈B-DNA微陣列
  • 比較基因組雜合反應
  • 序列生物資訊學
  • 全球組織微陣列市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 製藥和生物技術公司
  • 研究所
  • 醫院
  • 全球組織微陣列市場：免疫組織化學細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 自動化免疫組織化學
  • 手動免疫組織化學
  • 多重免疫組織化學
  • 全球組織微陣列市場：螢光原位雜合反應(FISH) 細分市場、類型、性能及預測（2019-2024 年、2024-2029 年、2034 年）
  • 單色魚
  • 多彩的魚
  • DNAFISH
  • 全球組織微陣列市場：冷凍組織陣列細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 冷凍樣本的組織微陣列
  • 速凍組織陣列
  • 全球組織微陣列市場：其他細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 核酸微陣列
  • RNA原位雜合反應
  • 石蠟包埋組織陣列

第7章 區域和國家分析

  • 全球組織微陣列市場：2019-2024 年、2024-2029 年與 2034 年區域表現與預測
  • 全球組織微陣列市場：國家、績效與預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 組織微陣列市場：競爭格局
  • 組織微陣列市場：公司簡介
    • Roche Group
    • Merck & Co. Inc.
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson Biosciences
    • Agilent Technologies Inc.

第31章：其他領先和創新企業

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • PerkinElmer Inc.
  • Bio-Techne Corporation
  • Tristar Group
  • Evotec SE
  • Precision For Medicine Inc.
  • Molecular Devices LLC
  • BioIVT LLC
  • BioChain Institute Inc.
  • Creative Bioarray Co
  • 3DHISTECH Ltd.
  • Novus Biologicals LLC
  • PREMIER Biosoft International Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年組織微陣列市場：提供新機會的國家
  • 2029年組織微陣列市場：細分市場帶來新機會
  • 2029年組織微陣列市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r25354u

A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.

The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tissue microarray research report is one of a series of new reports from The Business Research Company that provides tissue microarray market statistics, including the tissue microarray industry's global market size, regional shares, competitors with tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue microarray market size has grown strongly in recent years. It will grow from $12.05 billion in 2024 to $13.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to rise of precision medicine, drug discovery and development, efficient analysis, rising prevalence of chronic diseases, biobanking initiatives.

The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $20.85 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to emergence of digital pathology, expanded applications, growing biopharmaceutical industry, regulatory support and standards, ai and machine learning integration. Major trends in the forecast period include advancements in imaging technologies, development of 3d tissue microarrays, high-content screening, standardization initiatives, and single-cell analysis integration.

The forecast of 12.3% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for precision paraffin blocks and microarray printing components, sourced from key regions such as Finland and Canada, could lead to increased costs for high-throughput pathology research.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of cancer is expected to drive the growth of the tissue microarray market in the future. Cancer encompasses a range of diseases that can arise in any organ or tissue when abnormal cells multiply uncontrollably, breach their normal boundaries, and potentially spread to other organs or invade nearby tissues. Tissue microarrays are utilized in oncology to analyze the expression of cancer-related biomarkers in different tumor samples. For example, in June 2022, data published by Macmillan Cancer Support, a UK-based cancer charity, indicated that the number of individuals living with cancer reached 3 million in 2022, with projections suggesting it will rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Therefore, the increasing number of cancer cases is driving the growth of the tissue microarray market.

The growth of the tissue microarray market is further fueled by the rising demand for personalized medicine. Personalized medicine tailors medical treatment to individual characteristics for more effective healthcare. Tissue microarrays are instrumental in analyzing multiple tissue samples concurrently, facilitating rapid assessment of biomarkers. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs), with approximately 34% classified as personalized medicines. This emphasizes the integral role of tissue microarrays in advancing personalized medicine.

A notable trend in the tissue microarray market is the emergence of strategic partnerships. Major companies in the market are forming alliances to develop innovative tissue microarray technologies. For instance, The Cureline Group partnered with Cellecta Inc. to launch Tissue 2 Target Services, combining their competencies in molecular analysis and biospecimen management. Another collaboration involves Ultivue Inc. and ngTMA, aiming to advance multiplexed immunofluorescence assays and apply new tissue microarray technologies for spatial analysis in scientific research.

Companies in the tissue microarray market are focusing on advanced solutions, such as microarray platforms, to enhance precision and efficiency in high-throughput tissue analysis. MARGenomics launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform, the first in Europe and the United States to receive regulatory approval for diagnostic purposes. This platform, funded by the Carlos III Health Institute and the European Union's NextGenerationEU initiative, offers diverse functionalities for genomic and expression microarrays.

In November 2022, The Cureline Group, a US-based company specializing in preclinical and clinical research services, announced a partnership with Cellecta Inc. to launch Tissue 2 Target, which aims to enhance preclinical and translational research workflows. This collaboration will create a comprehensive resource for researchers focused on gene target and biomarker discovery, streamlining the molecular characterization of high-quality human biospecimens. By leveraging The Cureline Group's expertise in biospecimen management alongside Cellecta's functional genomics techniques, the partnership seeks to facilitate evidence-based decision-making, ultimately improving the outcomes of translational and preclinical programs. Cellecta, Inc., also based in the US, specializes in functional genomics and offers innovative tools for RNA interference and CRISPR-based research.

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Microarray Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Immunohistochemistry; Fluorescent In Situ Hybridization; Frozen Tissue Array; Other Types
  • 2) By Technology: Deoxyribonucleic Acid (DNA) Microarray; Polymerase Chain Reaction (PCR); Next-Generation Sequencing; Northern Blotting; Western Blotting
  • 3) By Application: Oncology; Gene Expression Profiling; Single Nucleotide Polymorphism (SNP) Detection; Double-Stranded B-DNA Microarrays; Comparative Genomic Hybridization; Sequencing Bioinformatics
  • 4) By End-User: Pharmaceutical And Biotechnological Companies; Research Organization; Hospitals
  • Subsegments:
  • 1) By Immunohistochemistry: Automated Immunohistochemistry; Manual Immunohistochemistry; Multiplex Immunohistochemistry
  • 2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH; Multi-Color FISH; DNA FISH
  • 3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples; Snap-Frozen Tissue Array
  • 4) By Other Types: Nucleic Acid Microarrays; RNA In Situ Hybridization; Paraffin-Embedded Tissue Array
  • Companies Mentioned: Roche Group; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Becton, Dickinson Biosciences; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; Qiagen NV; PerkinElmer Inc.; Bio-Techne Corporation; Tristar Group; Evotec SE; Precision For Medicine Inc.; Molecular Devices LLC; BioIVT LLC; BioChain Institute Inc.; Creative Bioarray Co; 3DHISTECH Ltd.; Novus Biologicals LLC; PREMIER Biosoft International Inc.; iSpecimen Inc.; OriGene Technologies Inc.; Bio SB Inc.; ProteoGenex Inc.; Z Biotech LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Microarray Market Characteristics

3. Tissue Microarray Market Trends And Strategies

4. Tissue Microarray Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tissue Microarray Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tissue Microarray PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tissue Microarray Market Growth Rate Analysis
  • 5.4. Global Tissue Microarray Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tissue Microarray Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tissue Microarray Total Addressable Market (TAM)

6. Tissue Microarray Market Segmentation

  • 6.1. Global Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunohistochemistry
  • Fluorescent In Situ Hybridization
  • Frozen Tissue Array
  • Other Types
  • 6.2. Global Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Deoxyribonucleic Acid (DNA) Microarray
  • Polymerase Chain Reaction (PCR)
  • Next-Generation Sequencing
  • Northern Blotting
  • Western Blotting
  • 6.3. Global Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Gene Expression Profilinng
  • Single Nucleotide Polymorphism (SNP) Detection
  • Double-Stranded B-DNA Microarrays
  • Comparative Genomic Hybridization
  • Sequencing Bioinformatics
  • 6.4. Global Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnological Companies
  • Research Organization
  • Hospitals
  • 6.5. Global Tissue Microarray Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Immunohistochemistry
  • Manual Immunohistochemistry
  • Multiplex Immunohistochemistry
  • 6.6. Global Tissue Microarray Market, Sub-Segmentation Of Fluorescent In Situ Hybridization (FISH), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Color FISH
  • Multi-Color FISH
  • DNA FISH
  • 6.7. Global Tissue Microarray Market, Sub-Segmentation Of Frozen Tissue Array,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tissue Microarray from Frozen Samples
  • Snap-Frozen Tissue Array
  • 6.8. Global Tissue Microarray Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleic Acid Microarrays
  • RNA In Situ Hybridization
  • Paraffin-Embedded Tissue Array

7. Tissue Microarray Market Regional And Country Analysis

  • 7.1. Global Tissue Microarray Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tissue Microarray Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Microarray Market

  • 8.1. Asia-Pacific Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Microarray Market

  • 9.1. China Tissue Microarray Market Overview
  • 9.2. China Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Microarray Market

  • 10.1. India Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Microarray Market

  • 11.1. Japan Tissue Microarray Market Overview
  • 11.2. Japan Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Microarray Market

  • 12.1. Australia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Microarray Market

  • 13.1. Indonesia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Microarray Market

  • 14.1. South Korea Tissue Microarray Market Overview
  • 14.2. South Korea Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Microarray Market

  • 15.1. Western Europe Tissue Microarray Market Overview
  • 15.2. Western Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Microarray Market

  • 16.1. UK Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Microarray Market

  • 17.1. Germany Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Microarray Market

  • 18.1. France Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Microarray Market

  • 19.1. Italy Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Microarray Market

  • 20.1. Spain Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Microarray Market

  • 21.1. Eastern Europe Tissue Microarray Market Overview
  • 21.2. Eastern Europe Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Microarray Market

  • 22.1. Russia Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Microarray Market

  • 23.1. North America Tissue Microarray Market Overview
  • 23.2. North America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Microarray Market

  • 24.1. USA Tissue Microarray Market Overview
  • 24.2. USA Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Microarray Market

  • 25.1. Canada Tissue Microarray Market Overview
  • 25.2. Canada Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Microarray Market

  • 26.1. South America Tissue Microarray Market Overview
  • 26.2. South America Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Microarray Market

  • 27.1. Brazil Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Microarray Market

  • 28.1. Middle East Tissue Microarray Market Overview
  • 28.2. Middle East Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Microarray Market

  • 29.1. Africa Tissue Microarray Market Overview
  • 29.2. Africa Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Microarray Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Microarray Market Competitive Landscape
  • 30.2. Tissue Microarray Market Company Profiles
    • 30.2.1. Roche Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson Biosciences Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Microarray Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen NV
  • 31.4. PerkinElmer Inc.
  • 31.5. Bio-Techne Corporation
  • 31.6. Tristar Group
  • 31.7. Evotec SE
  • 31.8. Precision For Medicine Inc.
  • 31.9. Molecular Devices LLC
  • 31.10. BioIVT LLC
  • 31.11. BioChain Institute Inc.
  • 31.12. Creative Bioarray Co
  • 31.13. 3DHISTECH Ltd.
  • 31.14. Novus Biologicals LLC
  • 31.15. PREMIER Biosoft International Inc.

32. Global Tissue Microarray Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Microarray Market

34. Recent Developments In The Tissue Microarray Market

35. Tissue Microarray Market High Potential Countries, Segments and Strategies

  • 35.1 Tissue Microarray Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tissue Microarray Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tissue Microarray Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer